Migraine Disorders: all 1,558 studies

Page 5 of 16. Open to participants first (301), then studies with results posted, then the rest; newest registration first within each.

• Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine PatientsCompletedNCT03867201Phase 3Results posted
• Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic MigraineCompletedNCT03855137Phase 3Results posted
• Vestibulodynia: Understanding Pathophysiology and Determining Appropriate TreatmentsCompletedNCT03844412Phase 2Results posted
• A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of MigraineCompletedNCT03836664Phase 2Results posted
• Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic MigraineCompletedNCT03828539Phase 4Results posted
• A Controlled Trial of Erenumab in Migraine PreventionCompletedNCT03812224Phase 3Results posted
• Adherence to and Beliefs on Recommendations for Behavioral Treatment for MigraineCompletedNCT03799211Not applicableResults posted
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic MigraineCompletedNCT03777059Phase 3Results posted
• Imaging the Migraine Brain Pre- and Post-ErenumabCompletedNCT03773562Phase 4Results posted
• Music Intervention on Migraine HeadachesCompletedNCT03763058Not applicableResults posted
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in AdultsCompletedNCT03732638Phase 2/3Results posted
• Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic MigraineCompletedNCT03712917Not applicableResults posted
• Clinical Decision Support for Patient Migraine ManagementCompletedNCT03706794Not applicableResults posted
• Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic MigraineCompletedNCT03700320Phase 3Results posted
• Onabotulinumtoxin Type A Reconstitution With Preserved Versus Preservative-free Saline in Chronic Migraine.CompletedNCT03698409Phase 4Results posted
• A Study of Lasmiditan (LY573144) Over Four Migraine AttacksCompletedNCT03670810Phase 3Results posted
• Sphenopalatine Ganglion Blocks RCTCompletedNCT03666663Phase 4Results posted
• The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of MigraineCompletedNCT03631550Not applicableResults posted
• CHOCOlate MeLatonin for AdolescenT MigrainECompletedNCT03597529Phase 2Results posted
• Vagus Nerve Stimulation and Stress Reduction Training for MigraineCompletedNCT03592329Not applicableResults posted
• A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant MigraineCompletedNCT03559257Phase 3Results posted
• Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301)CompletedNCT03557333Phase 3Results posted
• "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic MigraineCompletedNCT03543254Phase 2Results posted
• Occipital Blocks for Acute MigraineCompletedNCT03526874Phase 3Results posted
• pLatelEts And MigRaine iN patEnt foRamen OvaleCompletedNCT03521193Not applicableResults posted
• Introvision for Migraine and HeadachesCompletedNCT03507400Not applicableResults posted
• AMG 334 20160172 Pediatric Migraine PK Study.CompletedNCT03499119Phase 1Results posted
• Study to Determine Safety and Efficacy of B244 in Subjects With Episodic MigraineCompletedNCT03488563Phase 2Results posted
• A Phase III Trial of e-TNS for the Acute Treatment of MigraineCompletedNCT03465904Not applicableResults posted
• Trial in Adult Subjects With Acute MigrainesCompletedNCT03461757Phase 3Results posted
• Greater Occipital and Supraorbital Nerve Blockade in Migraine PatientsCompletedNCT03435185Not applicableResults posted
• Auricular Neurostimulation for Cyclic Vomiting SyndromeCompletedNCT03434652Not applicableResults posted
• Non-invasive Neurostimulation for the Relief of MigraineTerminatedNCT03410628Not applicableResults posted
• Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic MigraineCompletedNCT03400059Not applicableResults posted
• (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers ExistCompletedNCT03381261Phase 4Results posted
• Evaluation of a Novel Device for Treatment of Migraine HeadacheCompletedNCT03361423Not applicableResults posted
• Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in AdolescentsTerminatedNCT03338920Phase 3Results posted
• The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant UsersCompletedNCT03335163Phase 1Results posted
• Study of Efficacy and Safety of AMG 334 in Adult Episodic Migraine PatientsCompletedNCT03333109Phase 3Results posted
• An Efficacy and Safety Study of Fremanezumab in Adults With MigraineCompletedNCT03308968Phase 3Results posted
• Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of MigraineCompletedNCT03303105Phase 3Results posted
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Episodic MigraineCompletedNCT03303092Phase 2/3Results posted
• Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic MigraineCompletedNCT03303079Phase 2/3Results posted
• A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of MigraineCompletedNCT03282227Phase 3Results posted
• Greater Occipital Nerve Block Versus MetoclopramideCompletedNCT03269435Phase 4Results posted
• Open Label Safety Study in Acute Treatment of MigraineCompletedNCT03266588Phase 2/3Results posted
• A Study of Lasmiditan in Participants With MigraineCompletedNCT03247790Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine PreventionCompletedNCT03238781Phase 2Results posted
• Safety and Efficacy in Adult Subjects With Acute MigrainesCompletedNCT03237845Phase 3Results posted
• Safety and Efficacy Study in Adult Subjects With Acute MigrainesCompletedNCT03235479Phase 3Results posted
• Abortive Treatment of Migraine With the Cefaly® Abortive Program DeviceCompletedNCT03217968Not applicableResults posted
• The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen CombinationCompletedNCT03194555Phase 2Results posted
• Melatonin for Adolescent Migraine Prevention StudyTerminatedNCT03150797Phase 2Results posted
• Efficacy and Safety of IONIS-PKKRx for Preventive Treatment of Chronic MigraineCompletedNCT03108469Phase 2Results posted
• A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other TherapiesCompletedNCT03096834Phase 3Results posted
• Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain PopulationCompletedNCT03055767Phase 2Results posted
• Efficacy, Tolerability, and Safety of DFN-15CompletedNCT03009019Phase 3Results posted
• Efficacy, Tolerability, and Safety Study of DFN-15CompletedNCT03006276Phase 3Results posted
• A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine HeadacheTerminatedNCT02991430Not applicableResults posted
• An Open Label Trial of ALD403 (Eptinezumab) in Chronic MigraineCompletedNCT02985398Phase 3Results posted
• Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic MigraineCompletedNCT02974153Phase 3Results posted
• Efficacy of Haloperidol vs. Metoclopramide for Treatment of Acute Headaches and Migraines in the Emergency DepartmentTerminatedNCT02972502Phase 4Results posted
• Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)TerminatedNCT02964741Not applicableResults posted
• A Study of LY2951742 (Galcanezumab) in Japanese Participants With MigraineCompletedNCT02959190Phase 3Results posted
• A Study of LY2951742 (Galcanezumab) in Japanese Participants With Episodic MigraineCompletedNCT02959177Phase 2Results posted
• Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine HeadacheCompletedNCT02933060Phase 2/3Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of MigraineCompletedNCT02873221Phase 3Results posted
• Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of MigraineCompletedNCT02867709Phase 3Results posted
• An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)CompletedNCT02856802Phase 2Results posted
• Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine PreventionCompletedNCT02848326Phase 2/3Results posted
• Corticosteroids for Acute Migraine in the Emergency DepartmentCompletedNCT02847494Phase 4Results posted
• Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of MigraineCompletedNCT02828020Phase 3Results posted
• Oral Dexamethasone for the Treatment of Acute Migraine Recurrence in the Pediatric Emergency DepartmentCompletedNCT02794441Phase 3Results posted
• Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy FemalesCompletedNCT02792517Phase 1Results posted
• Biomarker Study in Participants With MigraineCompletedNCT02766517Early Phase 1Results posted
• An Exploratory Prospective Trial of Rescue Acupuncture for the Treatment of Acute MigraineCompletedNCT02764996Not applicableResults posted
• The MOTS (Medication Overuse Treatment Strategy) TrialCompletedNCT02764320Not applicableResults posted
• Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of MigraineCompletedNCT02745392Phase 2/3Results posted
• Spectacle Tints and Thin-Films for MigraineTerminatedNCT02720211Not applicableResults posted
• Ketamine for Acute Migraine in the Emergency DepartmentCompletedNCT02697071Not applicableResults posted
• Mindfulness and Mechanisms of Pain Processing in Adults With MigrainesCompletedNCT02695498Not applicableResults posted
• RCT of Non-Invasive Vagus Nerve Stimulation (nVNS) With gammaCore®, for the Acute Treatment of Migraine AttacksCompletedNCT02686034Not applicableResults posted
• Greater Occipital Nerve Block With Bupivacaine for Acute MigraineCompletedNCT02665273Phase 3Results posted
• Efficacy and Safety of Subcutaneous Administration of Fremanezumab (TEV-48125) for the Preventive Treatment of MigraineCompletedNCT02638103Phase 3Results posted
• Timolol Eye Drops in the Treatment of Acute Migraine HeadacheTerminatedNCT02630719Not applicableResults posted
• A Safety and Efficacy Study to Evaluate AMG 334 in Migraine PreventionCompletedNCT02630459Phase 2Results posted
• Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic MigraineCompletedNCT02629861Phase 3Results posted
• Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic MigraineCompletedNCT02621931Phase 3Results posted
• A Safety Study of Galcanezumab in Participants With Migraine, With or Without AuraCompletedNCT02614287Phase 3Results posted
• Evaluation of Galcanezumab in the Prevention of Chronic MigraineCompletedNCT02614261Phase 3Results posted
• Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 StudyCompletedNCT02614196Phase 3Results posted
• Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 StudyCompletedNCT02614183Phase 3Results posted
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigraineCompletedNCT02605174Phase 3Results posted
• Metformin for the Prevention of Episodic Migraine (MPEM)CompletedNCT02593097Phase 3Results posted
• Acute Treatment of Migraine With e-TNSCompletedNCT02590939Not applicableResults posted
• Pilot Study of Two Different Strengths of DFN-11 Injection for Rapidly Escalating MigraineCompletedNCT02571049Phase 2Results posted
• DFN-11 Injection in Episodic Migraine With or Without AuraCompletedNCT02569853Phase 3Results posted
• Ginger Capsules for the Acute Treatment of Migraine AttacksCompletedNCT02568644Not applicableResults posted
• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineCompletedNCT02565186Phase 3Results posted
• A Multicenter Assessment of ALD403 in Frequent Episodic MigraineCompletedNCT02559895Phase 3Results posted

← Migraine Disorders overview